Back to search

United Kingdom· GB-APID-3013111000001101

Ebixa 10mg tablets

A memantine product containing memantine, registered in United Kingdom by Lundbeck Ltd. The same ATC class is registered in 18 of our 19 countries.

ATC N06DX01

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedEbixa 10mg tabletsATCN06DX01REGISTER NO.GB-APID-3013111000001…PACKS LISTED5CHECKEDSeptember 13, 2026

Where it is registered

Memantine is registered in 18 of 19 countries.

Countries holding a registration under ATC N06DX01 (memantine), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 11 of them publish a price we can compare per daily dose

Memantine · ATC N06DX01

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of memantine costs, country by country.

Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.22 in United States to $2.93 in Spain — a ×13 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Memantine · price per daily dose (20 mg)

USD · FX 28 Sept 2026

  • ES Spain$2.93
  • CH Switzerland$2.47
  • IT Italy$0.77
  • US United States$0.22 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Memantine
Manufacturer
Lundbeck Ltd
Country
United Kingdom (GB)
ATC code
N06DX01
ATC class
Memantine
Defined daily dose
20 mg, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 5

  • gtin
    5702157127054
  • gtin
    05702150148919
  • gtin
    05702150154231
  • gtin
    5702157127153
  • gtin
    5702157127252

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

139 interactions on record for memantine.

Graded by severity as the source publishes them — 42 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Memantine · interactions on record

139 records

  • 42 moderate
  • 11 minor
  • 80 info

Most severe, free to view

  • DicycloverineA03AA07moderate
  • PropanthelineA03AB05moderate
  • MepenzolateA03AB12moderate
  • TrospiumA03AB20moderate

6 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Memantine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All memantine products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Alsemora, Memantin 1a Pharma
  • Belgium · Alsemora, Memantine Eg
  • Bulgaria · Memantine Grindeks, Имана
  • Cyprus · Alzedem, Mantomed
  • Czechia · Cognomem, Mantomed
  • Germany · Alsemora, Memantin
  • Denmark · Alsemora, Marbodin
  • Estonia · Alsemora, Mantomed
  • Spain · Alsemora, Mantinex
  • Finland · Alsemora, Marbodin
  • France · Alsemora, Memantine Arrow Lab
  • Greece · Almerzac, Alsemora
  • Croatia · Alsemora, Mantomed
  • Hungary · Memantin Goodwill, Memantin Stada
  • Ireland · Memantine Clonmel, Memantine Grindeks
  • Iceland · Axura, Ebixa
  • Italy · Demenco, Ezemantis
  • Liechtenstein · Axura, Memantine Accord
  • Lithuania · Alsemora, Maryzola
  • Luxembourg · Memantine Eg
  • Latvia · Alsemora, Mantomed
  • Malta · Memantine Aurobindo, Memantine Clonmel
  • Netherlands · Alsemora, Mantomed
  • Norway · Alsemora, Axura
  • Poland · Auromemo, Biomentin
  • Portugal · Alsemora, Mantinex
  • Romania · Alsemora, Memantina Atb
  • Sweden · Alsemora, Marbodin
  • Slovenia · Alsemora, Mantomed
  • Slovakia · Alsemora, Mantomed

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7a4e5179-4844-4d89-979e-b4dee22588e3
GET /v1/drugs/7a4e5179-4844-4d89-979e-b4dee22588e3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "3013111000001101",
  "desc": "Ebixa 10mg tablets (Lundbeck Ltd)",
  "form": "Oral tablet",
  "vpid": "42037411000001100",
  "source": "dmd",
  "vtm_id": "776669005",
  "strength": "10 mg",
  "substance": "Memantine",
  "ingredient": "Memantine hydrochloride",
  "supplier_code": "2075801000001108"
}

See everything about memantine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.